News - Hortons Pharmacy

Bristol Myers Squibb Appoints New Leader for Drug Development

Bristol Myers Squibb has named Dr. Cristian Massacesi as its new Executive Vice President and Chief Medical Officer, overseeing all […]

A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from

European drug regulators have recommended rejecting Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), in a setback for its

Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre.

The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to

Earlier this year, EyePoint Pharmaceuticals faced doubts about its drug-device combo, Duravyu, after it failed in a study for nonproliferative

Here’s a simplified version of the text: There’s a rare heart condition known as transthyretin amyloidosis cardiomyopathy that has caught

In the pharmaceutical world, there’s a big competition to create the best obesity drugs, currently dominated by Novo Nordisk and

Here’s a simplified summary of the regulatory updates for various pharmaceutical products: 1. Pfizer’s Elrexfio: Recommended in England for multiple

Thorsten Stafforst recalls being discouraged from pursuing his research. In the early 2010s, scientists were excited about CRISPR, a tool